Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Minerva Neurosciences, Inc (NERV) had Normalized Income after Taxes of $-9.02M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-9.02M |
|
-- |
|
-- |
|
$7.17M |
|
$-7.17M |
|
$-1.85M |
|
$-9.02M |
|
$-9.02M |
|
$-9.02M |
|
$-9.02M |
|
$-9.02M |
|
|
Normalized Income after Taxes |
$-9.02M |
$-7.17M |
|
$-7.16M |
|
6.51M |
|
6.51M |
|
$-1.15 |
|
$-1.15 |
|
| Balance Sheet Financials | |
$42.00M |
|
$0.01M |
|
$14.90M |
|
$56.90M |
|
$3.34M |
|
-- |
|
$82.02M |
|
$85.36M |
|
$-28.46M |
|
$-43.33M |
|
$-28.46M |
|
6.99M |
|
| Cash Flow Statement Financials | |
$-14.78M |
|
-- |
|
$19.60M |
|
$36.19M |
|
$41.01M |
|
$4.82M |
|
$1.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
31.71% |
|
20.82% |
|
-15.86% |
|
31.71% |
|
$-4.07 |
|
$-2.27 |
|
$-2.27 |
|